Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland DG, Coutre SE (2004) The HP1L1-PDIGFRA fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 103:2879–2891
2. Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL et al (2004) FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 104:3038–3045
3. Bacher U, Reiter A, Haferlach T, Mueller L, Schnittger S, Kern W et al (2006) A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia. Haematologica 91(6):817–820
4. Chusid MJ, Dale DC, West BC, Wolf SM (1975) Hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54(1):1–27
5. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J et al (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of Imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 27348(13):1201–1214